Skip to main content

TOX4 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88320

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88320

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of human TOX4. Peptide sequence: RCVRSGCENPPIVSKDWDNEYCSNECVVKHCRDVFLAWVASRNSNTVVFV The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for TOX4 Antibody

Western Blot: TOX4 Antibody [NBP2-88320]

Western Blot: TOX4 Antibody [NBP2-88320]

Western Blot: TOX4 Antibody [NBP2-88320] - Host: Rabbit. Target Name: TOX4. Sample Type: Lung tumor lysates. Antibody Dilution: 1.0ug/ml

Applications for TOX4 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: TOX4

Alternate Names

C14orf92, chromosome 14 open reading frame 92, Epidermal Langerhans cell protein LCP1, KIAA0737MIG7, LCP1, migration-inducing protein 7, TOX high mobility group box family member 4

Gene Symbol

TOX4

Additional TOX4 Products

Product Documents for TOX4 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TOX4 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...